Sarepta Therapeutics, Inc.
SRPT
$16.66
$0.261.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -403.27% | -322.84% | -222.54% | -1,570.01% | 143.89% |
| Total Depreciation and Amortization | 18.02% | 28.68% | 3.31% | -6.88% | -15.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.02% | 58.84% | 47.62% | 270.98% | -49.57% |
| Change in Net Operating Assets | 110.89% | 47.91% | 15.61% | 1.89% | -48.95% |
| Cash from Operations | 0.15% | 30.60% | 24.15% | -2.52% | 58.92% |
| Capital Expenditure | 25.54% | -15.73% | -36.68% | -49.56% | -79.95% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.77% | 1,842.34% | 1,288.87% | 182.13% | 1,095.04% |
| Cash from Investing | -90.78% | 1,111.52% | 343.32% | 506.38% | 555.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -239,000.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -51.33% | -45.85% | -56.37% | 61.12% | 55.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -142.88% | -- | -- | -- | -38.52% |
| Cash from Financing | -234.88% | -203.07% | -35.27% | 153.89% | -0.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.09% | 218.73% | 126.92% | 58.37% | 224.51% |